BioWorld MedTech

Feb. 16, 2016

View Archived Issues

Cahaba proposes draft coverage of KRAS test for cetuximab therapy

Newly developed mini brains could dramatically alter drug discovery

FFOCT scanner brings real-time microscopy for biopsies into OR

Holiday notice

Other news to note

Regulatory front

MDD's Company Stock Report

Appointments and advancements

Products

MDD's Cardiology Extra

Embattled Sientra gets ready to go back to work after certification debacle

BOGOTA, Colombia — After facing an unprecedented crisis last year, breast implants company Sientra Inc. reported that it is ready to resume its commercial activities next month. Read More

T2 Biosystems hopes to gain market share with sepsis detection technologies

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 17, 2025.

Ouch! Tariffs hit med tech harder than expected

BioWorld MedTech

First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...

Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III

BioWorld

Days after Pfizer Inc. pulled the plug on its oral GLP-1 candidate danuglipron, Eli Lilly and Co. aired positive top-line data from the phase III trial called...

ADPD 2025: Novel treatment modalities in neurodegenerative disorders

BioWorld Science

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...